|
Volumn 96, Issue 12, 2004, Pages 898-900
|
New studies fan controversy over gender risk in lung cancer
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN;
GEFITINIB;
AGE;
ANAMNESIS;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RESEARCH;
CANCER RISK;
CANCER SUSCEPTIBILITY;
CASE CONTROL STUDY;
DRUG EFFICACY;
HEALTH HAZARD;
HORMONE ACTION;
HUMAN;
LUNG CANCER;
LUNG CARCINOGENESIS;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
SEX DIFFERENCE;
SMOKING;
UNITED STATES;
ARTICLE;
ECONOMICS;
FEMALE;
HEALTH CARE PERSONNEL;
INCIDENCE;
LUNG TUMOR;
MALE;
MORTALITY;
PREVALENCE;
PROSPECTIVE STUDY;
SEX RATIO;
SMOKING CESSATION;
SOCIAL BEHAVIOR;
STATISTICS;
CASE-CONTROL STUDIES;
FEMALE;
HEALTH PERSONNEL;
HUMANS;
INCIDENCE;
LUNG NEOPLASMS;
MALE;
MORTALITY;
PREVALENCE;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
SEX DISTRIBUTION;
SEX FACTORS;
SMOKING;
SMOKING CESSATION;
SOCIAL RESPONSIBILITY;
UNITED STATES;
|
EID: 2942635545
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.12.898 Document Type: Note |
Times cited : (9)
|
References (0)
|